Basic Information
Basic information for SOX2-OT-296-52aa
Peptide Name SOX2-OT-296-52aa
Genome Position chr3:181741707-181741862[+]
Species Human
Peptide Sequence MAWTLQVASKIDFDPLTLSHGGIASTLSKDLARNDSFPLSVIGDSINSLESK
Peptide Length 52
Unique No (SOX2-OT-207-52aa,SOX2-OT-218-52aa,SOX2-OT-225-52aa,SOX2-OT-234-52aa,SOX2-OT-276-52aa,SOX2-OT-283-52aa,SOX2-OT-285-52aa,SOX2-OT-287-52aa,SOX2-OT-291-52aa,SOX2-OT-292-52aa,SOX2-OT-293-52aa,SOX2-OT-294-52aa,SOX2-OT-295-52aa,SOX2-OT-297-52aa,SOX2-OT-298-52aa,SOX2-OT-299-52aa,SOX2-OT-303-52aa,SOX2-OT-304-52aa)
Grand Average of Hydropathicity 0.0423
Relative Molecular Mass 6467.05
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000242808;SOX2-OT
Transcript ID/Name ENST00000661842;SOX2-OT-296
Transcript Length 4077
Coding Ability 0.2862
DNA Sequence Corresponding to Peptide ATGGCCTGGACTCTCCAGGTGGCCTCCAAAATCGATTTTGACCCCCTGACCCTGTCTCACGGAGGCATAGCATCCACCCTAAGTAAGGATTTAGCCAGGAATGACAGCTTTCCACTGAGTGTTATTGGGGACAGTATAAACAGTTTGGAAAGCAAG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :